Cdc37 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

Cdc37 shRNA Plasmid (h)

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
Cdc37 shRNA Plasmid (h)

Product Specs
ItemCdc37 shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-29255-SH
Quantity20 µg
Vector Type (Standardized)Lentiviral
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene Namecell division cycle 37, HSP90 cochaperone
NCBI Gene AliasesP50CDC37
RNA TypeshRNA Clones

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Novel Small Molecule Hsp90/Cdc37 Interface Inhibitors Indirectly Target K-Ras-SignalingCancersFebruary 23, 2021Siddiqui FA, Parkkola H, Vukic V, Oetken-Lindholm C, Jaiswal A, Kiriazis A, Pavic K, Aittokallio T, Salminen TA, Abankwa D.

(2) Correlation between PDZK1, Cdc37, Akt and breast cancer malignancy: the role of PDZK1 in cell growth through Akt stabilization by increasing and interacting with Cdc37Molecular medicine (Cambridge, Mass.)July 14, 2014Kim H, Abd Elmageed ZY, Davis C, El-Bahrawy AH, Naura AS, Ekaidi I, Abdel-Mageed AB, Boulares AH.

(3) Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cellsJournal of virologySeptember 1, 2013Sun X, Bristol JA, Iwahori S, Hagemeier SR, Meng Q, Barlow EA, Fingeroth JD, Tarakanova VL, Kalejta RF, Kenney SC.

(4) Geldanamycin inhibits TGF-beta signaling through induction of Hsp70Archives of biochemistry and biophysicsMarch 1, 2010Yun CH, Yoon SY, Nguyen TT, Cho HY, Kim TH, Kim ST, Kim BC, Hong YS, Kim SJ, Lee HJ.

(5) 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell linesInvestigative ophthalmology & visual scienceJune 1, 2008Babchia N, Calipel A, Mouriaux F, Faussat AM, Mascarelli F.

Be the First to Write a Review!